MedPath

Role of Siddha medicine in the management of radiotherapy induced oral complications in cancer patients- an observational study

Phase 2
Completed
Conditions
Health Condition 1: C00-D49- Neoplasms
Registration Number
CTRI/2019/05/018888
Lead Sponsor
Ayothidoss pandithar hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
7
Inclusion Criteria

1.Cancer patients with past history of radiotherapy within past 1 year

2.Patients having oral complications of radiotherapy

3.Patients willing to participate in study

Exclusion Criteria

1.Patients treated with other modalities of cancer treatment

2.Patients not willing to participate in this study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To observe the role of Siddha medicines in the management of radiotherapy induced oral complications in cancer patientsTimepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
To observe improvement in xerostomia before and after treatment <br/ ><br>To observe taste acquity before and after treatmentTimepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath